AMIORG Stock Overview
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Ami Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,191.20 |
| 52 Week High | ₹1,388.95 |
| 52 Week Low | ₹1,004.45 |
| Beta | -0.24 |
| 1 Month Change | 2.73% |
| 3 Month Change | 4.54% |
| 1 Year Change | 16.94% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 27.40% |
Recent News & Updates
Recent updates
Ami Organics Limited Recorded A 7.8% Miss On Revenue: Analysts Are Revisiting Their Models
Feb 15
We Think That There Are Some Issues For Ami Organics (NSE:AMIORG) Beyond Its Promising Earnings
May 24Analysts Have Made A Financial Statement On Ami Organics Limited's (NSE:AMIORG) Annual Report
May 20Ami Organics Limited's (NSE:AMIORG) Earnings Haven't Escaped The Attention Of Investors
Apr 01Shareholder Returns
| AMIORG | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.9% | 0.8% | 0.5% |
| 1Y | 16.9% | 58.6% | 44.7% |
Return vs Industry: AMIORG underperformed the Indian Pharmaceuticals industry which returned 57.7% over the past year.
Return vs Market: AMIORG underperformed the Indian Market which returned 44.8% over the past year.
Price Volatility
| AMIORG volatility | |
|---|---|
| AMIORG Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: AMIORG has not had significant price volatility in the past 3 months.
Volatility Over Time: AMIORG's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 602 | Naresh Patel | www.amiorganics.com |
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers approximately 520 pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries.
Ami Organics Limited Fundamentals Summary
| AMIORG fundamental statistics | |
|---|---|
| Market cap | ₹43.93b |
| Earnings (TTM) | ₹417.01m |
| Revenue (TTM) | ₹6.79b |
105.4x
P/E Ratio6.5x
P/S RatioIs AMIORG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMIORG income statement (TTM) | |
|---|---|
| Revenue | ₹6.79b |
| Cost of Revenue | ₹3.86b |
| Gross Profit | ₹2.93b |
| Other Expenses | ₹2.52b |
| Earnings | ₹417.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | 11.31 |
| Gross Margin | 43.19% |
| Net Profit Margin | 6.14% |
| Debt/Equity Ratio | 15.7% |
How did AMIORG perform over the long term?
See historical performance and comparison